About Contact Us Careers

Sterile Injectable Drugs Market Share

Request Free Sample Copy

Report ID: 3050
Published Date: Dec 24, 2024
Report Format: PDF, PPT

Buy Now

Sterile Injectable Drugs Market Share

Regionally, the sterile injectable drugs market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America industry is likely to dominate majority revenue share by 2037, led by high investment in healthcare sector, along with increasing medical R&D activities in the region. The market in the Asia Pacific is estimated to witness a noteworthy growth during the forecast period, owing to the improving healthcare sector backed by rising disposable income and economic development in the region.

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Sterile Injectable Drugs Market Size & Share, Growth Report 2037 [2025 Updated]

Author Credits: Radhika Pawar

Report ID: 3050
Published Date: Dec 24, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of sterile injectable drugs is evaluated at USD 663.79 billion.

Sterile Injectable Drugs Market size was valued at USD 636.21 billion in 2024 and is set to exceed USD 1.21 trillion by 2037, registering over 5.1% CAGR during the forecast period i.e., between 2025-2037.

North America industry is likely to dominate majority revenue share by 2037, led by high investment in healthcare sector, along with increasing medical R&D activities in the region.

The major players in the market are GlaxoSmithKline plc, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, AbbVie Inc., Amgen Inc., Novartis AG, Progenity, Inc., Johnson & Johnson Services, Inc. and others.

Inquiry Before Buying Request Free Sample